Skip to main content
. 2019 Mar;11(3):1047–1055. doi: 10.21037/jtd.2019.02.76

Table 1. Characteristics of subjects presenting to the clinic from the community.

Characteristics Group one: will be treated before supervising, n (%) Group two: will be treated after supervising, n (%) P value
Age (years), m ± SD 35.6±18.5 34.6±16.3 0.77
Gender
   F 24 (53.33) 26 (57.78) 0.671
   M 21 (46.67) 19 (42.22)
Level of asthma control
   Uncontrolled 29 (64.44) 24 (53.33) 0.236
   Partly controlled 8 (17.78) 6 (13.33)
   Well controlled 8 (17.78) 15 (33.33)
Adequacy of therapy: was he treated with the right dose of ICS +/− LABA
   Over treated 13 (28.89) 18 (40.00) 0.53
   Undertreated 28 (62.22) 24 (53.33)
   Well treated 4 (8.89) 3 (6.67)
Adherence 3 (6.67) 4 (8.89) 0.694
Prescription of oral corticosteroids 8 (17.78) 6 (13.33) 0.56
Good inhaler technique 4 (8.89) 8 (17.78) 0.215
Ventolin as needed 25 (55.56) 30 (66.67) 0.28
Antibiotics prescription 2 (4.44) 2 (4.44) 1
Antihistamine prescription 6 (13.33) 8 (17.78) 0.561
Antileukotrienes prescriptions 4 (8.89) 4 (8.89) 1
Peak flow percent predicted before bronchodilators (%), m ± SD 59±0.15 61±0.15 0.37
Peak flow percent predicted after bronchodilators (%), m ± SD 71±0.16 76±0.13 0.12
Cigarette smoker 13 (28.89) 12 (26.67) 0.814
Narghile smoker 5 (11.11) 7 (15.56) 0.535
Passive smoker cigarette 9 (20.00) 5 (11.11) 0.203
Passive smoker narghile 6 (13.33) 4 (8.89) 0.555
Asthma appeared after the war 29 (64.44) 32 (71.11) 0.499
Stress feeling 37 (82.22) 32 (71.11) 0.215
Asthma exaggerated by stress 37 (82.22) 39 (86.67) 0.561

ICS, inhaled corticosteroid.